JPRN-UMIN000010912招募中未知
The curative effect of Diquafosol Sodium ophthalmic solution 3% to the diabetic who has the amount fall of tear fluid secretion, and an anterior-epithelium-of-cornea obstacle. - The curative effect of Diquafosol Sodium ophthalmic solution 3% to the diabetic who has the amount fall of tear fluid secretion, and an anterior-epithelium-of-cornea obstacle.
Tokyo Women's Medical University School of Medicine0 个研究点目标入组 45 人开始时间: 2013年6月10日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.The user of a contact lens (used within one week or the existing patient who is going to use a contact lens during medical treatment observation) 2.The patient who has the past of cornea refractive surgery. 3.The patient currently diagnosed as meibomian gland dysfunction. 4.The patient suffered from eye infection or a serious allergic conjunctival disease. 5.The patient currently diagnosed as the cicatricial angle conjunctival disease (eye pemphigoid, and Stevens-Johnson syndrome and alkali externally caused injury are included). 6.The patient who has the past of an inner eye operation (laser surgery is included) within three months before an observation start. 7.The patient who was continuing the medical treatment (a punctum plug insertion way, a surgical punctum closing way, etc.) aiming at the blockade of punctum before the observation term start till less than one month. 8.The patient who is performing dry eye auxiliary medical treatment which has on pharmacometrics, such as glasses for dry eye protection. 9.The patient who has eyeblink insufficiency. 10.The patient who has a schedule which adds an applying- ophthalmic solution during exam. 11.The patient with the schedule which uses the medicine (treatment) provided in the regulation about a concomitant drug (treatment) during exam. 12.The patient who had complications of the heart, liver, the kidney, blood dyscrasia, and others, and was judged to be unsuitable on pharmacometrics. 13.The patient who there is under pregnancy and breast-feeding or a possibility of having become pregnant, or wishes to become pregnant within one month after the scheduled end of an observation period.
研究者
相似试验
已完成
不适用
The effect of diquafosol sodium ophthalmic solution on visual function in patients following cataract surgeryCataractJPRN-UMIN000015659Keio University School of Medicine90
尚未招募
不适用
The effect of diquafosol sodium ophthalmic solutions on the microbial flora of ocular surfacedry eye and prosthesisJPRN-UMIN000006395Tokushima University Hospital20
已完成
不适用
The effect of diquafosol sodium ophthalmic solution on visual function in patients following cataract surgery exploratory study.cataractJPRN-UMIN000010973Keio university30
尚未招募
不适用
Effects of 3% diquafosol sodium ophthalmic solution on visual function in patient with dry eye wearing contact lens.dry eyeJPRN-UMIN000010975Minamiaoyama Eye Clinic Tokyo20
已完成
不适用
Clinical effects of 3% diquafosol ophthalmic solution in dry eye disease patients using VDTDry EyeJPRN-UMIN000008990Tokyo Electric Power hospital100